Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC

Published 2017 View Full Article

Authors

Keywords

Liver cancer, Carcinoma, hepatocellular, Advanced BCLC, Brivanib, mRECIST, Objective response, Surrogate end-point, Response evaluation criteria in solid tumours

Journal

JOURNAL OF HEPATOLOGY

Volume 66, Issue 6, Pages 1166-1172

Publisher

Elsevier BV

Online

2017-01-26

DOI

10.1016/j.jhep.2017.01.012

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started